Joint modeling of multiple longitudinal patient-reported outcomes and survival

Journal of Biopharmaceutical Statistics

Volumn 21, Issue 5, 2011, Pages 971-991

  Hatfield, Laura A ^a   Boye, Mark E ^b   Carlin, Bradley P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cancer; Failure time; Multivariate analysis; Random effects model; Repeated measures

Indexed keywords

ARTICLE; LONGITUDINAL STUDY; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL MODEL; SURVIVAL;

ANTIMETABOLITES, ANTINEOPLASTIC; BAYES THEOREM; CLINICAL TRIALS, PHASE III AS TOPIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; GLUTAMATES; GUANINE; HUMANS; LONGITUDINAL STUDIES; MESOTHELIOMA; MODELS, STATISTICAL; NEOPLASMS; RESEARCH DESIGN; RESEARCH REPORT; SELF REPORT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80051709085     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2011.590922     Document Type: Article

References (50)

1. Branscum, A., Gardner, I., Johnson, W. (2004). Bayesian modeling of animal- and herd-level prevalences. Journal of Veterinary Medicine 66:101-112. (Pubitemid 39569138)
2. Brooks, S., Gelman, A. (1998). General methods for monitoring convergence of iterative simulations. Journal of Computational and Graphical Statistics 7:434-455. (Pubitemid 128635035)
3. Brown, E., Ibrahim, J. (2003). A Bayesian semiparametric joint hierarchical model for longitudinal and survival data. Biometrics 59:221-228. (Pubitemid 36750335)
4. Brown, E., Ibrahim, J., DeGruttola, V. (2005). A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics 61:64-73. (Pubitemid 40380965)
5. Celeux, G., Forbes, F., Robert, C., Titterington, D. (2006). Deviance information criteria for missing data models. Bayesian Analysis 1:651-674.
6. Chen, M.-H., Ibrahim, J., Sinha, D. (2004). A new joint model for longitudinal and survival data with a cure fraction. Journal of Multivariate Analysis 91:18-34. (Pubitemid 39007498)
7. Chi, Y.-Y., Ibrahim, J. (2006). Joint models for multivariate longitudinal and multivari- ate survival data. Biometrics 62:432-445. (Pubitemid 43926648)
8. Chi, Y.-Y., Ibrahim, J. (2007). Bayesian approaches to joint longitudinal and survival models accommodating both zero and nonzero cure fractions. Statistica Sinica 17:445-462.
9. Dunson, D., Herring, A. (2005). Bayesian latent variable models for mixed discrete outcomes. Biostatistics 6:11-25. (Pubitemid 41240366)
10. Elashoff, R., Li, G., Li, N. (2008). A joint model for longitudinal measurements and survival data in the presence of multiple failure types. Biometrics 64:762-771.
11. Faucett, C., Schenker, N., Elashoff, R. (1998). Analysis of censored survival data with intermittently observed time-dependent binary covariates. Journal of the American Statistical Association 93:427-437.
12. Faucett, C., Thomas, D. (1996). Simultaneously modelling censored survival data and repeatedly measured covariates: A Gibbs sampling approach. Statistics in Medicine 15:1663-1685. (Pubitemid 26261589)
13. Fitzmaurice, G., Davidian, M., Verbeke, G., Molenberghs, G. eds. (2009). Longitudinal Data Analysis. Boca Raton, FL: Chapman & Hall/CRC.
14. Fredheim, O., Borchgrevink, P., Saltnes, T., Kaasa, S. (2007). Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Journal of Pain and Symptom Management 34:657-665. (Pubitemid 350167512)
15. Gelman, A., Carlin, J., Stern, H., Rubin, D. (2004). Bayesian Data Analysis. Boca Raton, FL: Chapman & Hall/CRC.
16. Gelman, A., Rubin, D. (1992). Inference from iterative simulation using multiple sequences. Statistical Science 7:457-472.
17. Ghosh, P., Albert, P. (2009). A Bayesian analysis for longitudinal semicontinuous data with an application to an acupunture clinical trial. Computational Statistics and Data Analysis 53:699-706.
18. Hanson, T., Branscum, A., Johnson, W. (2010). Predictive comparison of joint longitudinalsurvival modeling: a case study illustrating competing approaches. Lifetime Data Analysis (online ahead of print). Doi: 10.1007/s10985-010-9162-0.
19. Henderson, R., Diggle, P., Dobson, A. (2000). Joint modeling of longitudinal measurements and event time data. Biostatistics 4:465-480. (Pubitemid 33213549)
20. Hollen, P., Gralla, R., Kris, M. (1995). An overview of the lung cancer symptom scale. In: Assessing Quality of Life in Patients with Lung Cancer: A Guide for Clinicians. New York: NCM Publishers, pp. 57-63.
21. Hollen, P., Gralla, R., Liepa, A., Symanowski, J., Rusthoven, J. (2006). Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): Psychometric properties of the LCSS-Meso. Supportive Care in Cancer 14:11-21. (Pubitemid 43119592)
22. Hu, C., Sale, M. (2003). A joint model for nonlinear longitudinal data with informative dropout. Journal of Pharmacokinetics and Pharmacodynamics 30:83-103. (Pubitemid 36571070)
23. Huzurbazar, A. (2005). Flowgraph Models for Multistate Time-to-Event Data. Hoboken, NJ: John Wiley & Sons.
24. Ibrahim, J., Chen, M.-H., Sinha, D. (2002). Bayesian Survival Analysis. New York: Springer- Verlag.
25. Ibrahim, J., Chu, H., Chen, L. (2010). Basic concepts and methods for joint models of longitudinal and survival data. Journal of Clinical Oncology 28:2796-2801.
26. Jassem, J., Ramlau, R., Santoro, A., Schuette, W., Chemaissani, A., Hong, S., Blatter, J., Adachi, S., Hanauske, A., Manegold, C. (2008). Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. Journal of Clinical Oncology 26:1698-1704.
27. Joly, F., Vardy, J., Pintilie, M., Tannock, I. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology 18:1935-1942. (Pubitemid 350286228)
28. Lachenbruch, P. (2002). Analysis of data with excess zeros. Statistical Methods in Medical Research 11:297-302.
29. Lin, H., McCulloch, C., Mayne, S. (2002). Maximum likelihood estimation in the joint analysis of time-to-event and multiple longitudinal variables. Statistics in Medicine 21:2369-2382.
30. Lunn, D. (2003). WinBUGS Development Interface (WBDev). ISBA Bulletin 10:10-11.
31. Lunn, D., Thomas, A., Best, N., Spiegelhalter, D. (2000). WinBUGS-A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics and Computing 10:325-337.
32. Markman, M. (2009). Surrogate efficacy endpoints in oncology trials. Pharmaceutical Medicine 23:283-287.
33. Moinpour, C., Donaldson, G., Redman, M. (2007). Do general dimensions of quality of life add clinical value to symptom data?. Journal of the National Cancer Institute Monographs 37:31-38.
34. Rizopoulos, D., Verbeke, G., Lesaffre, E., Vanrenterghem, Y. (2008). A two-part joint model for the analysis of survival and longitudinal binary data with excess zeros. Biometrics 64:611-619. (Pubitemid 351691918)
35. Spiegelhalter, D., Best, D., Carlin, B., Van Der Linde, A. (2002). Bayesian measures of model complexity and fit (with discussion). Journal of the Royal Statistical Society, Series B 64:583-639.
36. Sturtz, S., Ligges, U., Gelman, A. (2005). R2WinBUGS: A package for running WinBUGS from R. Journal of Statistical Software 12:1-16. (Pubitemid 40218003)
37. Tseng, Y.-K., Hseih, F., Wang, J.-L. (2005). Joint modelling of accelerated failure time and longitudinal data. Biometrika 92:587-603. (Pubitemid 41241595)
38. Tsiatis, A., Davidian, M. (2004). Joint modeling of longitudinal and time-to-event data: An overview. Statistica Sinica 14:809-834. (Pubitemid 39499214)
39. Tsiatis, A., DeGruttola, V., Wulfsohn, M. (1995). Modeling the relationship of survival to longitudinal data measured with error: Applications to survival and CD4 counts in patients with AIDS. Journal of the American Statistical Association 90:27-37.
40. Tuma, R. (2009). Progression-free survival remains debatable endpoint in cancer trials. Journal of the National Cancer Institute 101:1439-1441.
41. van der Linde, A. (2005). DIC in variable selection. Statistica Neerlandica 59:45-56. (Pubitemid 40405925)
42. van Meerbeeck, J., Scherpereel, A., Surmont, V., Baas, P. (2011). Malignant pleural mesothelioma: The standard of care and challenges for future management. Critical Reviews in Oncology/Hematology 78:92-111.
43. Vogelzang, N., Rusthoven, J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., Niyikiza, C., Paoletti, P. (2003). Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. Journal of Clinical Oncology 21:2636-2644. (Pubitemid 46606305)
44. Wang, Y., Taylor, J. (2001). Jointly modeling longitudinal and event time data with application to acquired immunodeficiency syndrome. Journal of the American Statistical Association 96:895-905.
45. Wulfsohn, M., Tsiatis, A. (1997). A joint model for survival and longitudinal data measured with error. Biometrics 53:330-339. (Pubitemid 27131905)
46. Xu, J., Zeger, S. (2001a). Joint analysis of longitudinal data comprising repeated measures and times to events. Journal of the Royal Statistical Society Series C: Applied Statistics 50:375-387. (Pubitemid 33399970)
47. Xu, J., Zeger, S. (2001b). The evaluation of multiple surrogate endpoints. Biometrics 57:81-87. (Pubitemid 32200140)
48. Yau, K., Lee, A., Ng, A. (2002). A zero-augmented gamma mixed model for longitudinal data with many zeros. Australian and New Zealand Journal of Statistics 44:177-183.
49. Yu, M., Law, N., Taylor, J., Sandler, H. (2004). Joint longitudinal-survival-cure models and their application to prostate cancer. Statistica Sinica 14:835-862. (Pubitemid 39499215)
50. Zhang, M., Strawderman, R., Cowen, M., Wells, M. (2006). Bayesian inference for a two-part hierarchical model: An application to profiling providers in managed health care. Journal of the American Statistical Association 101:934-945. (Pubitemid 44424592)